Z. Laron, Somatomedin-1 (recombinant insulin-like growth factor-1) - Clinical pharmacology and potential treatment of endocrine and metabolic disorders, BIODRUGS, 11(1), 1999, pp. 55-70
Insulin-like growth factor (IGF-1) is a polypeptide of 70 amino acids. The
circulatory form of IGF-I is synthesised in the liver. The metabolic activi
ty of IGF-1 is regulated by 6 IGF-binding proteins (BPs), the most importan
t being IGFBP-3, IGF-1 acts via its own receptor, which resembles that of i
nsulin, It has been demonstrated that the effects of growth hormone (GH) on
protein metabolism, including growth and the effect on nerve tissue versus
trophic effects, are mediated by IGF-1, whereas these 2 hormones are antag
onistic in their effects on insulin and some aspects of lipid metabolism Th
is paper reviews present knowledge on the physiological role of IGF-I and c
linical effects of recombinant IGF-1 (somatomedin-1).
The biosynthesis of somatomedin-l in 1986 enabled the initiation of clinica
l trials. Somatomedin-l has many potential uses in the clinic. The most imp
ortant is replacement therapy in primary IGF-I deficiency, such as Laron sy
ndrome (primary GH resistance or insensitivity) and in patients who have de
veloped antibodies to hGH. In Laron syndrome, which is characterised by dwa
rfism, somatomedin-1 stimulates growth and increases muscle and bone mass,
as well as normalising blood chemistry. In types I and 2 (insulin-dependent
and non-independent) diabetes mellitus, somatomedin-l increases the sensit
ivity to insulin and improves glucose utilisation.
Experimental studies indicate that IGF-I has a role in nerve tissue metabol
ism, and in humans may contribute to healing of injured nerve tissue. Other
current clinical trials using the anabolic properties of somatomedin-1 are
studying its effect on osteoporosis, catabolic states (burns, post-operati
on. AIDS) and haematopoietic disorders. Adverse effects of somatomedin-1 ap
pear to be related to overdosage.
In conclusion, somatomedin-1 is an important hormone which has a promising
role as replacement therapy and appears to have many other potential applic
ations in the clinic.